loading...

otherref

BDI / TDI


Other bibliographic references

 

 


TDI                              BDI                                BDI/TDI

 

 

BDI/TDI- Bibliographic references:


Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC. Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest. 2007 Oct;132(4):1283-90. Epub 2007 Jul 23

Versteegh MI, Braun J, Voigt PG, Bosman DB, Stolk J, Rabe KF, Dion RA. Diaphragm plication in adult patients with diaphragm paralysis leads to long-term improvement of pulmonary function and level of dyspnea. Eur J Cardiothorac Surg. 2007 Sep;32(3):449-56. Epub 2007 Jul 19

Lechtzin N, Lange DJ, Davey C, Becker B, Mitsumoto H. Measures of dyspnea in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2007 Jan;35(1):98-102

Mahler DA, Witek TJ Jr. The MCID of the transition dyspnea index is a total score of one unit. COPD. 2005 Mar;2(1):99-103. Review

Doll H, Miravitlles M. Health-Related QOL in Acute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease : A Review of the Literature. Pharmacoeconomics. 2005;23(4):345-63

Jadad A, Rizo C, Cubillos P, Stahl E. Measuring symptom response to pharmacological interventions in patients with COPD: a review of instruments used in clinical trials. Curr Med Res Opin. 2004 Dec;20(12):1993-2005. Review

Mahler DA, Ward J, Fierro-Carrion G, Waterman LA, Lentine TF, Mejia-Alfaro R, Baird JC. Development of Self-Administered Versions of Modified Baseline and Transition Dyspnea Indexes in COPD. J COPD. 2004; 1:165-172

Witek TJ Jr, Mahler DA. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol. 2003 Mar;56(3):248-55

Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J. 2003 Feb;21(2):267-72(Full text article)

Aaron SD, Vandemheen KL, Clinch JJ, Ahuja J, Brison RJ, Dickinson G, Hebert PC. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest. 2002 Mar;121(3):688-96

de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002 Apr;121(4):1092-8

Mancini I, Body JJ. Assessment of dyspnea in advanced cancer patients. Support Care Cancer. 1999 Jul;7(4):229-32. Review

Nield MA. Inspiratory muscle training protocol using a pressure threshold device: effect on dyspnea in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 1999 Jan;80(1):100-2

Piquette CA, Clarkson L, Okamoto K Et Al. Respiratory-Related Quality Of Life: Relation To Pulmonary Function, Functional Exercise Capacity, And Sputum Biophysical Properties. Journal Of Aerosol Medicine 2000;13(3):263-272

Saffran L, Ost DE, Fein AM, Schiff MJ. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest. 2000 Aug;118(2):417-21

Scharf SM, Rossoff L, McKeon K, Graver LM, Graham C, Steinberg HN. Changes in pulmonary mechanics after lung volume reduction surgery. Lung. 1998;176(3):191-204

Weg IL, Rossoff L, McKeon K, Michael Graver L, Scharf SM. Development of pulmonary hypertension after lung volume reduction surgery. Am J Respir Crit Care Med. 1999 Feb;159(2):552-6

Keller CA, Ruppel G, Hibbett A, Osterloh J, Naunheim KS. Thoracoscopic lung volume reduction surgery reduces dyspnea and improves exercise capacity in patients with emphysema. Am J Respir Crit Care Med. 1997 Jul;156(1):60-7(Full text article)

Sassi-Dambron DE, Eakin EG, Ries AL, Kaplan RM. Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies. Chest. 1995 Mar;107(3):724-9(Full text article)

 

BDI - Bibliographic references:


Coleta KD, Silveira LV, Lima DF, Rampinelli EA, Godoy I, Godoy I. Predictors of first-year survival in patients with advanced COPD treated using long-term oxygen therapy. Respir Med. 2008 Apr;102(4):512-8. Epub 2008 Jan 10

Yoshimi S, Tanabe N, Masuda M, Sakao S, Uruma T, Shimizu H, Kasahara Y, Takiguchi Y, Tatsumi K, Nakajima N, Kuriyama T. Survival and quality of life for patients with peripheral type chronic thromboembolic pulmonary hypertension. Circ J. 2008 Jun;72(6):958-65

Camelier A, Rosa FW, Nascimento OA, Fernandes AL, Jardim JR. [Discriminative properties and validity of a health status questionnaire in obstructive airway disease patients: the Airway Questionnaire 20] Arch Bronconeumol. 2007 Dec;43(12):662-8. Spanish

Collet F, Mallart A, Bervar JF, Bautin N, Matran R, Pattou F, Romon M, Perez T. Physiologic correlates of dyspnea in patients with morbid obesity. Int J Obes (Lond). 2007 Apr;31(4):700-6. Epub 2006 Sep 26

Hartsell WF, Scott CB, Dundas GS, Mohiuddin M, Meredith RF, Rubin P, Weigensberg IJ. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03. Am J Clin Oncol. 2007 Aug;30(4):368-76

Ilonen IK, Räsänen JV, Sihvo EI, Knuuttila A, Sovijärvi AR, Sintonen H, Salo JA. Pneumonectomy: post-operative quality of life and lung function. Lung Cancer. 2007 Dec;58(3):397-402. Epub 2007 Aug 22

Zimmermann CS, Carvalho CR, Silveira KR, Yamaguti WP, Moderno EV, Salge JM, Kairalla RA, Carvalho CR. Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients. Braz J Med Biol Res. 2007 Feb;40(2):179-87

Teixeira CA, Dos Santos JE, Silva GA, de Souza ES, Martinez JA. Prevalence of and the potential physiopathological mechanisms involved in dyspnea in individuals with class II or III obesity. J Bras Pneumol. 2007 Feb;33(1):28-35. English, Portuguese

Oga T, Nishimura K, Tsukino M, Hajiro T, Mishima M. Dyspnoea with activities of daily living versus peak dyspnoea during exercise in  male patients with COPD. Respir Med. 2006 Jun;100(6):965-71. Epub 2005 Nov 18

Dourado VZ, Antunes LC, Tanni SE, de Paiva SA, Padovani CR, Godoy I. Relationship of upper-limb and thoracic muscle strength to 6-min walk distance in COPD patients. Chest. 2006 Mar;129(3):551-7

Hu J, Meek P. Health-related quality of life in individuals with chronic obstructive pulmonary  disease. Heart Lung. 2005 Nov-Dec;34(6):415-22

Gonzalez E, Herrejon A, Inchaurraga I, Blanquer R. Determinants of health-related quality of life in patients with pulmonary emphysema. Respir Med. 2005 May;99(5):638-44. Epub 2004 Nov 11

Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP; Scleroderma Lung Study Group. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005 Feb;52(2):592-600

Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, Nishimura K. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med. 2005 Apr;99(4):408-14

Hodgev V, Kostianev S, Marinov B. University of Cincinnati Dyspnea Questionnaire for Evaluation of Dyspnoea during physical and speech activities in patients with chronic obstructive pulmonary disease: a validation analysis. Clin Physiol Funct Imaging. 2003 Sep;23(5):269-74

Martinez-Moragon E, Perpina M, Belloch A, de Diego A, Martinez-Frances M. Determinants of dyspnea in patients with different grades of stable asthma. J Asthma. 2003 Jun;40(4):375-82

Nguyen HQ, Altinger J, Carrieri-Kohlman V, Gormley JM, Stulbarg MS. Factor analysis of laboratory and clinical measurements of dyspnea in patients with chronic obstructive pulmonary disease. J Pain Symptom Manage. 2003 Feb;25(2):118-27

Sant'Anna CA, Stelmach R, Zanetti Feltrin MI, Filho WJ, Chiba T, Cukier A. Evaluation of health-related quality of life in low-income patients with COPD receiving long-term oxygen therapy. Chest. 2003 Jan;123(1):136-41

Weiner P, Magadle R, Beckerman M, Weiner M, Berar-Yanay N. Comparison of specific expiratory, inspiratory, and combined muscle training programs in COPD. Chest. 2003 Oct;124(4):1357-64

Witek TJ Jr, Mahler DA. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol. 2003 Mar;56(3):248-55

Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J. 2003 Feb;21(2):267-72

Martinez J, Martinez T, Galhardo F, Pereira C. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Med Sci Monit. 2002 Jun;8(6):CR405-10

Finnerty JP, Keeping I, Bullough I. The Effectiveness Of Outpatient Pulmonary Rehabilitation In Chronic Lung Disease - A Randomized Controlled Trial. Chest 2001;119(6):1705-1710

Hodzhev VA, Kostianev SS, Marinov BI, Galabov ZN, Iluchev DH, Mandulova PV. A patient with a severe chronic airway obstruction and preserved exercise capacity (a case report). Folia Med (Plovdiv). 2001;43(4):54-7

Martinez TY, Pereira CA, dos Santos ML, Ciconelli RM, Guimaraes SM, Martinez JA. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest. 2000 Jun;117(6):1627-32

Scherer TA, Spengler CM, Owassapian D Et Al. Respiratory Muscle Endurance Training In Chronic Obstructive Pulmonary Disease - Impact On Exercise Capacity, Dyspnea, And Quality Of Life. Am J Respir Crit Care Med 2000;162:1709-1714

Elias Hernandez MT, Ortega Ruiz F, Sanchez Riera H, Otero Candelera R, Sanchez Gil R, Montemayor Rubio T. [Role of dyspnea in quality of life of the patient with chronic obstructive pulmonary disease] Arch Bronconeumol. 1999 Jun;35(6):261-6. Spanish

Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9

Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):785-90

Elias Hernandez MT, Ortega Ruiz F, Fernandez Guerra J, Toral Marin J, Sanchez Riera H, Montemayor Rubio T. [Comparison of a shuttle walking test with an exertion test with cycloergometer in patients with COPD] Arch Bronconeumol. 1997 Nov;33(10):498-502. Spanish

Ferrari K, Goti P, Misuri G, Amendola M, Rosi E, Grazzini M, Iandelli I, Duranti R, Scano G. Chronic exertional dyspnea and respiratory muscle function in patients with chronic obstructive pulmonary disease. Lung. 1997;175(5):311-9

Speich R, Boehler A, Russi EW, Weder W. A case report of a double-blind, randomized trial of inhaled steroids in a patient with lung transplant bronchiolitis obliterans. Respiration. 1997;64(5):375-80

O'Donnell DE, Webb KA, Bertley JC, Chau LK, Conlan AA. Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysema. Chest. 1996 Jul;110(1):18-27

Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest. 1995 Jun;107(6):1585-9(Full text article)

Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):467-70

Mahler DA, Faryniarz K, Tomlinson D, Colice GL, Robins AG, Olmstead EM, O'Connor GT. Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest. 1992 Aug;102(2):395-401

McParland C, Krishnan B, Wang Y, Gallagher CG. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis. 1992 Aug;146(2):467-72

O'Donnell DE, Webb KA. Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations. Chest. 1992 Sep;102(3):824-31

Read CA, Clauw D, Weir C, Da Silva AT, Katz P. Dyspnea and pulmonary function in the L-tryptophan-associated eosinophilia-myalgia syndrome. Chest. 1992 May;101(5):1282-6

Yang SC, Wu HD, Yang SP. Lung volume, diffusing capacity, chest roentgenogram and dyspnea index in interstitial lung disease. J Formos Med Assoc. 1991 Mar;90(3):244-9

Mahler DA, Harver A. Prediction of peak oxygen consumption in obstructive airway disease. Med Sci Sports Exerc. 1988 Dec;20(6):574-8

Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988 Mar;93(3):580-6

Mahler DA, Rosiello RA, Harver A, Lentine T, McGovern JF, Daubenspeck JA. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis. 1987 Jun;135(6):1229-33

 

TDI - Bibliographic references:


Bleecker ER, Emmett A, Crater G, Knobil K, Kalberg C. Lung function and symptom improvement with fluticasone propionate/salmeterol and  ipratropium bromide/albuterol in COPD: Response by beta-agonist reversibility. Pulm Pharmacol Ther. 2008 May 1. [Epub ahead of print]

Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Respir Med. 2008 Apr;102(4):479-87. Epub 2008 Feb 6

Hodder R, Kesten S, Menjoge S, Viel K. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with  inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis. 2007;2(2):157-67

Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, Mahler D, Saadeh C, Siler T, Snell P, Korenblat P, Smith W, Kaye M, Mandel M, Andrews C, Prabhu R, Donohue JF, Watt R, Lo KH, Schlenker-Herceg R, Barnathan ES, Murray J;  COPD Investigators. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007 May 1;175(9):926-34. Epub 2007 Feb 8

Adams SG, Anzueto A, Briggs DD Jr, Menjoge SS, Kesten S. Tiotropium in COPD patients not previously receiving maintenance respiratory medications. Respir Med. 2006 Sep;100(9):1495-503. Epub 2006 May 15

Verkindre C, Bart F, Aguilaniu B, Fortin F, Guerin JC, Le Merre C, Iacono P, Huchon G. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease. Respiration. 2006;73(4):420-7. Epub 2005 Nov 7

Make B, Hanania NA, ZuWallack R, Kalberg C, Emmett A, Brown CP, Knobil K. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. Clin Ther. 2005 May;27(5):531-42

Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005 Mar;127(3):809-17

Geddes EL, Reid WD, Crowe J, O'brien K, Brooks D. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: A systematic review. Respir Med. 2005 May 12; [Epub ahead of print]

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD. Treat Respir Med. 2004;3(3):173-81

Juan Samper G, Ramon Capilla M, Canto Armengod A, Lloret Perez T, Rubio Gomis E, Fontana Sanchis I, Marin Pardo J. [Body mass, dyspnea, and quality of life as success predictors in emphysema surgery for reduction of pulmonary volume] Rev Clin Esp. 2004 Dec;204(12):626-31. Spanish

Juan Samper G, Ramon Capilla M, Canto Armengol A, Martinez Perez ML, Lloret Perez T, Rubio Gomis E, Marin Pardo J. [Four-year results after lung volume reduction surgery for emphysema] Arch Bronconeumol. 2004 Oct;40(10):443-8. Spanish(Full text article)

Mahler DA, Huang S, Tabrizi M, Bell GM. Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study. Chest. 2004 Sep;126(3):926-34

Ando M, Mori A, Esaki H, Shiraki T, Uemura H, Okazawa M, Sakakibara H. The effect of pulmonary rehabilitation in patients with post-tuberculosis lung disorder. Chest. 2003 Jun;123(6):1988-95

Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest. 2003 Sep;124(3):834-43(Full text article)

Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest. 2003 May;123(5):1441-9(Full text article)

Witek TJ Jr, Mahler DA. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol. 2003 Mar;56(3):248-55

Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J. 2003 Feb;21(2):267-72

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002 Feb;19(2):217-24(Full text article)

Donohue JF, Van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ Jr, Kesten S, Towse L. A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol(*). Chest. 2002 Jul;122(1):47-55(Full text article)

Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, Shah T. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002 Oct 15;166(8):1084-91

Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, Cornelissen PJ. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002 Feb;19(2):209-16

Ambrosino N, Porta R. Measurement of dyspnoea. Monaldi Arch Chest Dis. 2001 Feb;56(1):39-42. Review

Flaherty KR, Kazerooni EA, Curtis JL, Iannettoni M, Lange L, Schork MA, Martinez FJ. Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT. Chest. 2001 May;119(5):1337-46

Sanchez Riera H, Montemayor Rubio T, Ortega Ruiz F, Cejudo Ramos P, Del Castillo Otero D, Elias Hernandez T, Castillo Gomez J. Inspiratory muscle training in patients with COPD: effect on dyspnea, exercise performance, and quality of life. Chest. 2001 Sep;120(3):748-56

Guyatt GH, King DR, Feeny DH et al. Generic and specific measurement of health-related quality of life in clinical trial of respiratory rehabilitation. Journal of Clinical Epidemiology 1999;52(3):187-192

Jamadar DA, Kazerooni EA, Martinez FJ, Wahl RL. Semi-quantitative ventilation/perfusion scintigraphy and single-photon emission tomography for evaluation of lung volume reduction surgery candidates: description and prediction of clinical outcome. Eur J Nucl Med. 1999 Jul;26(7):734-42

Ojo TC, Martinez F, Paine R 3rd, Christensen PJ, Curtis JL, Weg JG, Kazerooni EA, Whyte R. Lung volume reduction surgery alters management of pulmonary nodules in patients with severe COPD. Chest. 1997 Dec;112(6):1494-500

Ramirez-Venegas A, Ward JL, Olmstead EM, Tosteson AN, Mahler DA. Effect of exercise training on dyspnea measures in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 1997 Mar-Apr;17(2):103-9

Sciurba FC, Rogers RM, Keenan RJ, Slivka WA, Gorcsan J 3rd, Ferson PF, Holbert JM, Brown ML, Landreneau RJ. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med. 1996 Apr 25;334(17):1095-9

Lisboa C, Villafranca C, Pertuze J, Leiva A, Repetto P. [Clinical effects of inspiratory muscle training in patients with chronic airflow limitation] Rev Med Chil. 1995 Sep;123(9):1108-15. Spanish

Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT. Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med. 1995 Jan;151(1):61-5

 


Last update: June 2008